We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.85 | 4.70 | 5.00 | 4.85 | 4.85 | 4.85 | 16,585 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -11.55 | 25.87M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/4/2021 07:40 | Smith and Abrey already have substantial options. I do not see the need to further reward them for a job they should be doing anyway. | erinvale1 | |
01/4/2021 07:35 | So SuperSonico, you think it is OK to give free money to executives who are already being paid extremely well to do their job. The strike price of 6p is ludicrous. 60% below current market price. If top shareholders have approved this because they know the deal is about to be inked that speaks of corruption at the top of the company. Cronyism at its worst, and UK business practice at its least ethical. | ravenna23 | |
01/4/2021 07:25 | Erinvale Personally I don't think they are rewarding failure..my guess is they are rewarding a potentially massive deal which to date we are in the dark about..but I'm confident it's coming. That's what LuckyRobs Bayer folk are signalling imo. | supersonico | |
01/4/2021 07:18 | RNS today: In the announcement of the Company's fundraising on 28 February 2020, the Company stated that it would implement a new Long-Term Incentive Plan (LTIP) and replace options granted under the previous LTIP that are deemed a more appropriate scheme to incentivise management given the Company's stage of development. In line with that announcement, the Company has now granted replacement options over 10.5 million new Ordinary Shares in Eden, at a strike price of 6p each (being the placing price of the 2020 fundraise), in the amounts of 6 million awarded to Sean Smith and 4.5 million awarded to Alex Abrey. Why on earth is this company rewarding failure. This effectively gives Smith and Abrey an instant profit of 9p per share. THis is a smack in the face for shareholders in the face of serial management failure to achieve sales and take the company into profit. I notice, Supersonico, that you signalled that you were off this thread! | erinvale1 | |
01/4/2021 07:15 | LuckyRob (+2) Bayer folk who appreciate 'Eden Research partner gets the green light in Spain for bio-fungicide' post on Linked-in. As one who follows the story ( not the Unmentionable story the other one)I used to think that Tara Lu might have been a old mate of Robs who happened to be involved with Bayer in Biologicals and Biopesticide patents and that she followed his career closely. Methods of inhibiting, preventing, killing and/or repelling insects using simulated blends of chenopodium But then Wolfgang-Korzeniewsk But then maybe another friend of Rob who is kindly supportive pops up occasionally who has a Bayer Seed job as 'EMEA Business Portfolio Manager, Oilseed Rape Seeds at Bayer Crop Science' All I can say is lucky Rob having all these nice Bayer friends closely following his career so attentively and especially since Eden have no declared relationship with Bayer Crop Science. And there's more ..senior Bayer mates are coming out of the wood work.. Swantje Behnken Head of Target Biology bei Bayer Crop Science Michael Klueken Project Development Manager bei Bayer Crop Science | supersonico | |
01/4/2021 06:55 | quazie12 10 Feb '21 - 09:41 - 8814 of 8815 0 1 0 Maybe let Investing answer questions himself in future I’m sure he is a big boy. You need to maybe broaden your investment horizons, it will make you less twisted. Anyways no need to worry, I wont be back here. I hope that the fortunes of Eden have turned a corner and I wish investors well. | supersonico | |
31/3/2021 22:03 | If EDEN goes to zero tomorrow it does not change a single thing in my life. And I agree with you, there are plenty of stocks on AIM that spin plates for more funding, I could also name lots of them. We all like a gamble from time to time and what's the point of life without a little risk, there is no such thing as a sure thing.... | timbo_slice | |
31/3/2021 22:00 | GME - I meant Gamestop and I wondered what your thoughts were on a company exceeding it's valuation by several billion etc. | timbo_slice | |
31/3/2021 21:58 | Where should I invest? | timbo_slice | |
31/3/2021 21:07 | @ Timbo_Slice 31 Mar '21 - 10:29 - 9027 > Hi POV, what do you make of GME? Are you on WSB? I do not invest in AIM shares. Unless you are an insider of the company concerned, such shares are for fools. One has far, far better chances of a profit with the bookies, the National Lottery, a pinball or slot machine or even at a hoop-la at a fair than with AIM shares. The confidence of the genuine, eager PI in his (usually laughable) research that he is smarter than the ultra-shrewd institutionals, and smarter than me, is hilarious if it wasn't so tragic for him. He thinks he's seen an opportunity we, and the directors too (or he buys into their explanations for their generosity), haven't. I know almost nothing about EDEN. I don't need to. All I need to see is the relentless ramping here and on LSE, the nature of the share price chart and the cake-tomorrow nature of the rolling RNS fiascos. These tell me ALL I need to know. There is, of course, a small chance (vanishingly small) that I am wrong. I know 100s of AIM stocks like I know EDEN. All are IMO worthless. In a year or two their investors will be ruing their greed-fuelled folly. G e t o u t n o w. While you can. The little blip upwards early today was corrected by the close. Liquidity?? At 16:28:11 I could have bought a million of these, price similar to this morning. Yes, a million. Didn't try higher. Being sane, of course I didn't accept. Believe what you will about my motives. Judging by my reading the last thousand posts, Investor nous on this BB seems to me to be (even) lower for EDEN than the average for AIM stock. Make of that what you will. :-) IMHO, DYOR, YMMV, TINIA, JM2c | neutralpov | |
31/3/2021 19:09 | As one who follows the story ( not the sob story the other one)I used to think that Tara Lu might have been a old mate of Robs who happened to be involved with Bayer in Biologicals and Biopesticide patents and that she followed his career closely. Methods of inhibiting, preventing, killing and/or repelling insects using simulated blends of chenopodium But then Wolfgang-Korzeniewsk But then maybe another friend of Rob who is kindly supportive pops up occasionally who has a Bayer Seed job as 'EMEA Business Portfolio Manager, Oilseed Rape Seeds at Bayer Crop Science' All I can say is lucky Rob having all these nice Bayer friends closely following his career so attentively and especially since Eden have no declared relationship with Bayer Crop Science. And there's more ..Bayer mates are coming out of the wood work.. Swantje Behnken Head of Target Biology bei Bayer Crop Science Michael Klueken Project Development Manager bei Bayer Crop Science | supersonico | |
31/3/2021 18:41 | Yes i read that and its 48 days past that.The only difference is they didnt use short order or a covid excuse. Seem to remember lots of promises about back to school as well on another front too. | chrischas | |
31/3/2021 15:08 | As stated in AttyG's summary post: Trading Update 11 Feb 2021: "This process is currently moving forward, as expected, and the Company will provide an update as SOON AS IS PRACTIBLE." supersedes the previous - Eden Interim Presentation 14 Oct 2020: "Updates to follow before Q2 2021" | weyweyumfozo | |
31/3/2021 14:38 | Well if they can post spanish authorisation they can also post if there is going to be a delay in Corteva re by their original promise: "by the end of Q1 2021 claim" . | chrischas | |
31/3/2021 14:10 | paulpaolo Thanks for mentioning VOX. I have been looking for a small app for my phone and that one looks just the job. I am also confident in the Corteva outcome. Cheers | rustyke1 | |
31/3/2021 10:29 | Hi POV, what do you make of GME? Are you on WSB? | timbo_slice | |
31/3/2021 10:27 | Those two trades of 75k each are buys at 15.38p.It's pathetic that MM are still messing about with prints. | northwick | |
31/3/2021 09:38 | POV one post pointing out your disdain for this company may carry a bit of weight. Multiple never ending posts, suggests an ulterior motive. | iasike | |
31/3/2021 08:23 | @ Timbo_Slice 30 Mar '21 - 20:18 - 9017 of 9023 > Can you explain your reasoning a little bit more... obviously they have hired more staff... It fits, and perfectly, the profile of a ramped stock, and the conduct of the crooks and the desperate ones here plays a major role in such identification. @ grahamg8 31 Mar '21 - 07:18 > Yawn, yawn, yawn. More crops, more diseases, more countries. Where's the revenue? More importantly where's the profit? Spot on! @ erinvale1 31 Mar '21 - 07:29 - 9019 > Yes Graham: agreements, consultants, ‘addressable markets’ but no sales and no Corteva update. Spot on too! Honestly, the only bit that doesn't gel with this being a fleabitten ramped dog is the absence of rampers who are premium members. | neutralpov | |
31/3/2021 08:20 | @ paulpaolo 31 Mar '21 - 08:12 - 9022 > Spain grows a LOT of soft fruit, a lot of it under glass, so I am very pleased with this RNS. However, the really big RNS that'll give us £40m revenue and send us to the stars, is going to be the Corteva one, and every day at 07:00 I rush to Never read such utter tripe and bor-locks. It is GBP (£££££) that count. Not weasel-worded RNSs! You'd think divvies were paid in RNSs. Ultra-strong SELL recommendation in the light of the scale of deceitful ramping. This dog of a stock ranks in the top 20% of ramped AIM shares. And that is baaad. Fits the profile perfectly. > Meantime I bought a few more this morning at 15.42. Nice price. (Allegedly) posting his trades. Another sure sign of a ramper. How many different ones there are, and how many are multi-ID/sockpuppet avatars, is what I'm determining using the usual language analysis tools. Genuine PIs, you are in a den of lying wolves. Sell, run, enjoy the popcorn as this returns to its home base (zero pence). loL! | neutralpov | |
31/3/2021 08:12 | Spain grows a LOT of soft fruit, a lot of it under glass, so I am very pleased with this RNS. However, the really big RNS that'll give us £40m revenue and send us to the stars, is going to be the Corteva one, and every day at 07:00 I rush to VOX which shows RNS's on my watched stocks all in one place, hoping it's the day the Corteva RNS comes out from Eden. One day ! Meantime I bought a few more this morning at 15.42. Nice price. | paulpaolo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions